Literature DB >> 11174741

Late pulmonary valve replacement after repair of tetralogy of Fallot.

B Discigil1, J A Dearani, F J Puga, H V Schaff, D J Hagler, C A Warnes, G K Danielson.   

Abstract

BACKGROUND: Pulmonary regurgitation appears to be well tolerated early after repair of tetralogy of Fallot; however, it may result in progressive right ventricular dilatation and dysfunction necessitating eventual valve replacement. Our objective was to review our experience with late pulmonary valve replacement after complete repair of tetralogy of Fallot. METHODS AND
RESULTS: A total of 42 patients (16 female and 26 male) were operated on between July 1, 1974, and January 1, 1998. Mean age was 22 years (range 2-65 years). The mean interval between tetralogy repair and pulmonary valve replacement was 10.8 years (range 1.6 months-33 years). Mean follow-up was 7.8 +/- 6.0 years (maximum 23 years). Indications for pulmonary valve replacement included decreased exercise tolerance in 58%, right heart failure in 21%, arrhythmia in 14%, syncope in 10%, and progressive isolated right ventricular dilatation in 7%. Heterograft prostheses were used in 33 patients and homografts in 9. Five patients underwent isolated pulmonary valve replacement; concomitant procedures performed in 37 patients included tricuspid valve repair/replacement (n = 18), residual ventricular septal defect repair (n = 12), atrial septal defect closure (n = 4), pulmonary artery patch angioplasty (n = 17), and right ventricular outflow tract enlargement (n = 13). One patient died early (2%) of multiorgan failure. There were 6 late deaths, 3 of which were cardiac related. Survival was 95.1% +/- 3.4% and 76.4% +/- 8.9% at 5 and 10 years, respectively. Functional class of patients was improved significantly; preoperatively, 76% of patients were in New York Heart Association class III-IV, and after pulmonary valve replacement, 97% of surviving patients were in class I-II (P =.0001). Moderate to severe reduction in right ventricular function was noted on preoperative echocardiography in 59% and on late echocardiography in 18% (P =.03). Of the 5 patients who had supraventricular arrhythmias before pulmonary valve replacement, 1 had postoperative recurrence and the arrhythmia is controlled with antiarrhythmic therapy; the other 4 are in normal sinus rhythm at late follow-up. Eight patients subsequently underwent pulmonary valve re-replacement without early mortality at a mean interval of 9.0 +/- 4.2 years (range 3.8-16.8 years). Freedom from pulmonary valve re-replacement was 93.1% +/- 4.7% and 69.8% +/- 10.7% at 5 and 10 years, respectively. The only significant risk factor for re-replacement was young age at the time of the initial pulmonary valve replacement (P =.023).
CONCLUSION: Late pulmonary valve replacement after tetralogy repair significantly improves right ventricular function, functional class, and atrial arrhythmias, and it can be performed with low mortality. Subsequent re-replacement may be necessary to maintain functional improvement.

Entities:  

Mesh:

Year:  2001        PMID: 11174741     DOI: 10.1067/mtc.2001.111209

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  36 in total

1.  The unnatural history of tetralogy of Fallot: surgical repair is not as definitive as previously thought.

Authors:  C van Doorn
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

Review 2.  Assessment of ventricular function and mass by cardiac magnetic resonance imaging.

Authors:  Khaled Alfakih; Scott Reid; Tim Jones; Mohan Sivananthan
Journal:  Eur Radiol       Date:  2004-07-17       Impact factor: 5.315

Review 3.  Right ventricular function late after total repair of tetralogy of Fallot.

Authors:  Alexander van Straten; Hubert W Vliegen; Mark G Hazekamp; Albert de Roos
Journal:  Eur Radiol       Date:  2005-02-22       Impact factor: 5.315

Review 4.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

Review 5.  The right ventricle in congenital heart disease.

Authors:  P A Davlouros; K Niwa; G Webb; M A Gatzoulis
Journal:  Heart       Date:  2006-04       Impact factor: 5.994

6.  Cardiovascular magnetic resonance in the assessment of repaired tetralogy of Fallot.

Authors:  Francisco Alpendurada; Philip J Kilner
Journal:  Int J Cardiovasc Imaging       Date:  2008-08-07       Impact factor: 2.357

7.  Pulmonary valve replacement long after repair of tetralogy of Fallot.

Authors:  Yuichi Shiokawa; Hiromichi Sonoda; Yoshihisa Tanoue; Takahiro Nishida; Atsuhiro Nakashima; Ryuji Tominaga
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-08

8.  Intensive care outcome of adult patients operated on for congenital heart disease.

Authors:  Luc Jacquet; Olivier Vancaenegem; Jean Rubay; Fatima Laarbaui; Céline Goffinet; Robin Lovat; Philippe Noirhomme; Gebrine El Khoury
Journal:  Intensive Care Med       Date:  2006-12-20       Impact factor: 17.440

9.  Isolated pulmonary valve replacement: analysis of 27 years of experience.

Authors:  Shigehiko Tokunaga; Munetaka Masuda; Akira Shiose; Yukihiro Tomita; Shigeki Morita; Ryuji Tominaga
Journal:  J Artif Organs       Date:  2008-10-05       Impact factor: 1.731

10.  Coexistence of mitral regurgitation and pulmonary regurgitation in an adult with surgically corrected tetralogy of Fallot.

Authors:  Dimitrios Z Mytas; Meletios A Kanakis; Lamprini K Kosma; Fotios A Mitropoulos
Journal:  BMJ Case Rep       Date:  2012-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.